1. Mohammadi M, Mirzaei M. Population attributable fraction of cardiovascular disease associated with diabetes mellitus in Yazd city. J Shahid Sadoughi Univ Med Sci. 2017;25(8):603–11.
2. Mohammadi M, Mirzaei M, Karami M. Potential impact fraction of ischemic heart disease associated with diabetes mellitus in Yazd- Iran. Iranian Journal of Epidemiology. 2018;13(4):299–307.
3. Fong DS, Aiello LP, Ferris FL, Klein R. Diabeticretinopathy. Diabetes Care. 2004;27:2540–53.
4. Powers A. Human diabetes mellitus. In: Kasper B, Fauci A, Longo D, editors. Harrison’s Principle of internal medicine. 16th ed. USA: McGrawhil; 2005. p. 16.
5. Hadaegh F, Khalili D, Fahimfar N, Tohid M, Eskandari F, Azizi F. Glucose intolerance and risk of cardiovascular disease in Iranian men and women: results of the 7.6-year follow-upof the Tehran lipid and glucose study (TLGS). J Endocrinol Investig. 2009;32:724–30.